We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
GLPG.AS

Price
21.34
Stock movement up
+0.18 (0.85%)
Company name
Galapagos N.V.
Exchange
(AS
,
Currency
EUR
)
Sector
Healthcare >
Biotechnology
Market cap
1.41B
Ent value
2.66B
Price/Sales
-
Price/Book
0.49
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
6.82
Forward P/E
-
PEG
-
EPS growth
-
1 year return
-21.49%
3 year return
-28.56%
5 year return
-36.43%
10 year return
-7.23%
Last updated: 2025-04-15

DIVIDENDS

GLPG.AS does not pay dividends or no data was received

VALUATION

Valuation Ratios

Valuation Ratios data
Trailing P/E6.82
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Valuation (Sales/Book Value) data
Price to Sales-
Price to Book0.49
EV to Sales-296.58

FINANCIALS

Per share

Per share data
Current share count65.90M
EPS (TTM)3.13
FCF per share (TTM)-6.25

Income statement

Income statement data
Revenue (TTM)-8.97M
Gross profit (TTM)-112.52M
Operating income (TTM)-194.93M
Net income (TTM)206.33M
EPS (TTM)3.13
EPS (1y forward)-0.70

Margins

Margins data
Gross margin (TTM)1254.40%
Operating margin (TTM)2173.09%
Profit margin (TTM)-2300.27%

Balance Sheet

Please create a free account or log in to access this chart
Balance Sheet data
Cash55.52M
Net receivables45.43M
Total current assets3.56B
Goodwill69.47M
Intangible assets173.43M
Property, plant and equipment0.00
Total assets4.17B
Accounts payable115.86M
Short/Current long term debt0.00
Total current liabilities351.23M
Total liabilities1.31B
Shareholder's equity2.86B
Net tangible assets0.00

Cash flow

Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-327.52M
Capital expenditures (TTM)84.39M
Free cash flow (TTM)-411.91M
Dividends paid (TTM)0.00

Financial returns

Please create a free account or log in to access this chart
Financial returns data
Return on Equity7.21%
Return on Assets4.95%
Return on Invested Capital7.21%
Cash Return on Invested Capital-14.39%

STOCK INFORMATION

Stock chart

Stock price data
Open21.50
Daily high21.82
Daily low21.18
Daily Volume145K
All-time high249.50
1y analyst estimate36.50
Beta0.06
EPS (TTM)3.13
Dividend per share-
Ex-div date-
Next earnings date30 Apr 2025

Downside potential

Downside potential data
GLPG.ASS&P500
Current price drop from All-time high-91.45%-12.04%
Highest price drop-91.58%-56.47%
Date of highest drop7 Apr 20259 Mar 2009
Avg drop from high-34.92%-11.07%
Avg time to new high28 days12 days
Max time to new high1320 days1805 days
COMPANY DETAILS
GLPG.AS (Galapagos N.V.) company logo
Marketcap
1.41B
Marketcap category
Small-cap
Description
Galapagos NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667 that has completed phase 1b trial; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in Phase1/2 trial in relapsed/refractory non-hodgkin lymphoma; GLPG5201, a CD19 CAR-T product candidates manufactured at point-of-care, currently in phase 1/2 trial in replapsed/refractory chronic lymphocytic leukemia; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc.; and AbbVie S.à r.l. Galapagos NV was incorporated in 1999 and is headquartered in Mechelen, Belgium.
Employees
1123
Website
https://www.glpg.com
Investor relations
-
SEC filings
GLPG.AS SEC filings
CEO
Country
Netherlands
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
UNDERSTAND THE BUSINESS
COMPANY NEWS
All newsPress releases
No items found
Disclaimer
Skyfall Technology OÜ assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness. Please also note, that any action you take upon the information provided on this website is strictly at your own risk. This website is intended to be used and must be used for informational purposes only and you should take independent financial advice from a professional and independently research and verify everything you see on the site.
Menu
HomePortfolio ManagementCompany ScreenerGreen InvestmentExchangesContact Us
Language
ENHUNOSVDAFIESDENLFRITPTPLCSSKROELTRRUAF
© 2024 Skyfall Technology OÜ All Rights Reserved